Long-Term Use of Proton Pump Inhibitors Increases the Risk of Renal Diseases | ||||
| Azhar International Journal of Pharmaceutical and Medical Sciences | ||||
| Article 1, Volume 5, Issue 1, January 2025, Page 1-16 PDF (373.72 K) | ||||
| Document Type: Review Articles | ||||
| DOI: 10.21608/aijpms.2024.378587 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Amira Fayed  1; Eman A Mohamed2; Aya M Shaheen 3; Amany Balah 2
| ||||
| 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt | ||||
| 2Department of Pharmacology and Toxicology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt | ||||
| 3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt | ||||
| Abstract | ||||
| Proton pump inhibitors (PPIs) are drugs that successfully inhibit stomach acid secretion. It is used for the management of various acid-related conditions, including gastroesophageal reflux disease (GERD) and other gastric illnesses. It can reduce hydrochloric acid output via irreversible binding to the hydrogen potassium adenosine triphosphatase (H+/K+ ATPase) and inhibiting its action in the stomach. PPIs are among the most often prescribed drugs, however, 25% to 70% of these prescriptions have no legitimate indication. As a result, patients frequently take these treatments without benefit exposing themselves to unwanted adverse events. PPIs can cause acute interstitial nephritis (AIN), which can be a serious side effect associated with acute kidney injury (AKI). It has been reported that using PPIs for a long time has been associated with an elevated risk of chronic kidney disease (CKD). As a result, this review aims to investigate the adverse effects of long-term use of PPIs on renal function | ||||
| Keywords | ||||
| Proton pump inhibitors; acute kidney injury; chronic kidney disease; acute interstitial nephritis; adverse effects | ||||
|
Statistics Article View: 487 PDF Download: 419 |
||||
